Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
New to investing? Check out these zero fee investment apps designed specifically for new investors to start building wealth.
28,005 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Tesla just posted its strongest quarter in years, with a delivery beat powered by Model 3 and Model Y. This deep dive...
A dramatic run in Celcuity shares drew attention from traders and long-term investors alike. This article explains th...
Anthropic's public listing signals a new wave of AI investment. This piece highlights which major tech names could ri...
ASML dominated the latest quarter with strong results and higher guidance. This article breaks down what that could m...
A major shift in ServiceNow's strategy, led by aggressive AI integration and larger enterprise contracts, could set t...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
As March moves unfold, the stock market today is colored by big auto headlines. Ford’s recall news sent ripples throu...
A Digi International VP sold a stake amid a fast-changing IoT landscape. This article breaks down what such insider m...
As Serve Robotics prepares to release its Q4 results after the market closes on March 11, investors are weighing whet...
Investors are abuzz over SpaceX’s potential IPO, yet a new danger lurks: leveraged ETFs designed to double daily move...
Wake up to a clear, actionable investing briefing. This Thursday reads roundup distills ten essential market themes i...